A Case of Recurrent Salivary Duct Carcinoma Negative to HER-2/neu and Androgen Receptor Successfully Treated with Chemoradiation with Docetaxel
暂无分享,去创建一个
[1] R. Tishler,et al. Trastuzumab for the treatment of salivary duct carcinoma. , 2013, The oncologist.
[2] Julie M. Batten,et al. Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment , 2012, Clinical Cancer Research.
[3] T. Ettl,et al. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis. , 2012, Human pathology.
[4] S. Nam,et al. Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands. , 2012, The British journal of radiology.
[5] R. Tishler,et al. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy. , 2012, International journal of radiation oncology, biology, physics.
[6] T. Negri,et al. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). , 2009, Oral oncology.
[7] J. Sercarz,et al. Salivary duct carcinoma: A clinical and histologic review with implications for trastuzumab therapy , 2007, Head & neck.
[8] J. Gilbert,et al. Phase II trial of taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology Group , 2006, Head & neck.
[9] T. Löning,et al. Clinical and immunohistologic typing of salivary duct carcinoma , 2005, Cancer.
[10] K. Yamazaki,et al. Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature. , 2004, American journal of clinical pathology.
[11] C. Langer,et al. HER2 Expression in Salivary Gland Carcinomas , 2004, Clinical Cancer Research.
[12] Joseph I. Clark,et al. Response to paclitaxel and carboplatin in metastatic salivary gland cancer: A case report , 2002, Head & neck.
[13] Jun Yao,et al. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. , 1998, Molecular cell.